Energy Balance and Weight Gain With Ivacaftor Treatment of CFTR Gating Mutations
Phase of Trial: Phase II
Latest Information Update: 18 Jul 2018
Price : $35 *
At a glance
- Drugs Ivacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- 18 Jul 2018 Results published in the Journal of Pediatrics
- 17 Jul 2017 Status changed from active, no longer recruiting to completed.
- 16 Feb 2017 Planned End Date changed from 1 Jan 2017 to 1 Jun 2017.